European Ophthalmic Drugs & Devices Market Growth, Trends and Forecasts 2017 - 2022

  • ID: 4388024
  • Report
  • Region: Europe
  • 112 pages
  • Mordor Intelligence
1 of 4

Ophthalmic drugs and device market is expected to grow at an exponential rate in the coming years due to the impact in prevalence of eye disease and an increased growth in the percentage of the cataract population. The above developments have resulted in an increase in the production of new ophthalmic devices which in turn has caught the attention of the people. People are increasingly willing to opt for ophthalmic surgeries so that their eye disorders get treated effectively.

The European Ophthalmology Drugs and Devices Market is valued as a $10.5 billion market in 2013 and is expected to reach a value of $14 billion by 2018 at a CAGR of 5.92%.

The Global markets for ophthalmic drugs and devices are basically segmented into three categories. The first segmentation is on the basis of the device. This segment has its sub segments which are surgery/treatment devices and diagnostic imaging devices. The surgery instruments included lasers and other treatment based devices. The diagnostic based devices included microscopes, retinoscopes and slit lamps,etc. The other segmentations are done on the basis of different drugs used in the treatment of eye disorders. These included drugs for Glaucoma, infections and inflammations.

The major drivers for this market are the availability of new drugs and devices, huge demographic shift towards the emerging markets and the increase in the cataract population. The major constraints being expensive procedures, economic slowdown in developed markets.

The market is again divided on the basis of geography. In the global market US has the largest market share. In the European sector UK has the major share. Recent developments and analysis show that the emerging markets are rapidly rising due to the increase in the cataract population and are expected to show stiff competition against the major players like USA and UK.

The major companies with a share in this market are Novartis, Roche Diagnostics, Alcon, Gene Signal, GSK.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

1.INTRODUCTION
1.1 Report Description
1.2 Research Methodology
1.3 Stakeholders
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
3. MARKET OVERVIEW
3.1 Market Defenition
3.1.1 Introduction
3.2 Market Segmentation
3.2.1 Ophthalmic Diseases
3.2.2 Ophthalmic Drugs
3.2.3 Ophthalmic Devices
3.3 Market Drivers
3.3.1 Demographic shift and impact of prevalence of eye disease
3.3.2 Availability of new drugs and devices
3.3.3 Growth in Cataract Volume
3.4 Market Constraints
3.4.1 Increasing Healthcare costs
3.4.2 Economic Slowdown in developed markets
4. GLOBAL MARKETS: SEGEMENTATION BY DEVICE
4.1 Surgery/Treatment Mode
4.1.1 Ophthalmic Lasers
4.1.2 Nd:YAG Laser
4.1.3 Excimer Laser
4.1.4 Femotosecond Laser
4.1.5 Cyclodiode Laser
4.1.6 Photocoagulation Lasers
4.1.7 Laser for Glaucoma
4.1.8 Surgery based devices
4.1.9 Cataract Surgery Devices
4.1.10 Intraocular Lens
4.1.11 Phakic
4.1.12 Aphakic
4.1.13 Pseudophakic
4.1.14 Phacoemulsification
4.1.15 Glaucoma Surgery Devices
4.1.16 Glaucoma Drainage Devices
4.1.17 Glaucoma Implants
4.1.18 Glaucoma Lasers
4.1.19 Glaucoma Shunts & Valves
4.1.20 Refractive Surgery Devices
4.1.21 Microkeratome
4.1.22 Intrastormal Rings
4.1.23 Diamond Knife
4.1.24 Solutions & Viscoelastics
4.1.25 Retinal Implants
4.2 Ophthalmic Diagnostic Devices
4.2.1 Opthalmoscope
4.2.2 Slit Lamps
4.2.3 Exophthalmometer
4.2.4 Keratometer
4.2.5 Tonometer
4.2.6 Phoropter
4.2.7 Ultrasounds
4.2.8 Fundus Camera
4.2.9 Retinoscope
4.2.10Lensometer
5. NORTH AMERICA: SEGEMENTATION BY TYPE OF DRUGS
5.1 Anti Glaucoma Drugs
5.2 Ophthalmic Infection Drugs
5.3 Ophthalmic Inflammation Durgs
5.4 Ophthalmic Lubricants
5.5 Mydriasis Drugs
5.6 Ophthalmic Swelling
6. EUROPEAN MARKETS: SEGMENTATION BY GEOGRAPHY
6.1 UK
6.2 Germany
6.3 Spain
6.4 France
7. Competitive Landscape
7.1 Introduction
7.2 Mergers & Acquisitions
7.3 Expansions
7.4 New Product Launch
7.5 Collaborations
8. COMPANY PROFILES
Alcon
Gene Signal
GSK
Roche
Novartis International,Inc.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll